Merck & Co., Inc.
MRK
$92.93
$1.481.62%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.03B | 16.41B | 17.43B | 17.12B | 12.15B |
| Total Depreciation and Amortization | 4.33B | 4.38B | 4.38B | 4.25B | 4.03B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 209.00M | 2.99B | 3.06B | 3.77B | 3.75B |
| Change in Net Operating Assets | -6.51B | -5.24B | -4.00B | -3.67B | -1.67B |
| Cash from Operations | 17.07B | 18.53B | 20.88B | 21.47B | 18.26B |
| Capital Expenditure | -4.02B | -3.81B | -3.84B | -3.37B | -3.42B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -2.00M | -3.35B | -3.35B | -4.09B | -4.09B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.00M | -387.00M | -659.00M | -269.00M | 1.28B |
| Cash from Investing | -3.98B | -7.55B | -7.85B | -7.73B | -6.24B |
| Total Debt Issued | 6.03B | 47.00M | 3.60B | 3.60B | 3.60B |
| Total Debt Repaid | -3.04B | -3.04B | -3.04B | -1.29B | -754.00M |
| Issuance of Common Stock | 57.00M | 48.00M | 109.00M | 177.00M | 171.00M |
| Repurchase of Common Stock | -4.32B | -3.44B | -2.35B | -1.31B | -1.21B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.11B | -8.03B | -7.94B | -7.84B | -7.74B |
| Other Financing Activities | -294.00M | -328.00M | -354.00M | -372.00M | -333.00M |
| Cash from Financing | -9.68B | -14.75B | -9.97B | -7.03B | -6.27B |
| Foreign Exchange rate Adjustments | 173.00M | 457.00M | 1.00M | -293.00M | 260.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.57B | -3.30B | 3.06B | 6.41B | 6.02B |